Cancer drug aids cell regeneration after spinal cord injury

In a study published today in Science (e-publication ahead of print), a global research team reports that the cancer drug Taxol (Paclitaxel) promotes the regeneration of injured nerve cells in the central nervous system (CNS) after spinal cord injury. Scientists from the Max Planck Institute of Neurobiology in Germany and the Kennedy Krieger Institute’s International Center for Spinal Cord Injury in Maryland, together with colleagues at the University of Utrecht in the Netherlands and University of Miami in Florida, found that the drug reduces the major obstacles to neural cell repair in the spinal cord of injured rats.

Read the whole article on Physorg

More from Physorg